Synthesis and characterization of fluorescent and photoactivatable MIP-1α ligands and interactions with chemokine receptors CCR1 and CCR5

Journal of Medicinal Chemistry

Volumn 44, Issue 2, 2001, Pages 215-222

  Zoffmann, S ^b   Turcatti, G ^a   Galzi, J L ^b   Dahl, M ^c   Chollet, A ^a  

^a SERONO PHARMACEUTICAL RES INSTITUTE   (Switzerland)

^b UNIVERSITÉ DE STRASBOURG   (France)

^c AARHUS UNIVERSITY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR1; CHEMOKINE RECEPTOR CCR5; FLUORESCENT DYE; IODIDE; LIGAND; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; SOLVENT; THIOCARBAMIC ACID DERIVATIVE; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; BINDING AFFINITY; BINDING SITE; COMPLEX FORMATION; COVALENT BOND; CROSS LINKING; EXTRACELLULAR MATRIX; NONHUMAN; PHOTOACTIVATION; PHOTOAFFINITY LABELING; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN PROTEIN INTERACTION; SYNTHESIS;

ANIMALS; CALCIUM; CHO CELLS; CRICETINAE; FLUORESCENT DYES; HUMANS; LIGANDS; MACROPHAGE INFLAMMATORY PROTEIN-1; PHOTOAFFINITY LABELS; RADIOLIGAND ASSAY; RECEPTORS, CCR5; RECEPTORS, CHEMOKINE; SPECTROMETRY, FLUORESCENCE; TRANSFECTION;

EID: 0035905860     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm000982i     Document Type: Article

References (26)

1. Chemokines
2. Chemokine receptors and their role in leukocyte activation
3. Chemokine receptors: Gateways to inflammation and infection
4. Chemokine receptors - Future therapeutic targets for HIV?
5. The amino-terminal domain of CCR2 is both necessary and sufficient for high affinity binding of monocyte chemoattractant protein 1
6. Two-site binding of C5a by its receptor: An alternative binding paradigm for G protein-coupled receptors
7. Benzophenone photophores in biochemistry
8. Identification of methionine as the site of covalent attachment of a p-benzoyl-phenylalanine-containing analogue of substance P on the substance P (NK1) receptor
9. Mapping peptide-binding domains of the substance P (NK1) receptor from P388D1 cells with photolabile agonists
10. Identification of angiotensin II-binding domains in the rat aT2 receptor with photolabile angiotensin analogues
11. Direct mapping of an agonist-binding domain within the parathyroid hormone/parathyroid hormone-related protein receptor by photoaffinity cross-linking
12. Identification of an interaction between residue 6 of the natural peptide ligand and a distinct residue within the amino-terminal tail of the secretin receptor
13. Direct identification of the agonist binding site in the human brain cholecystokinin B receptor
14. Probing the binding domain of the NK2 receptor with fluorescent ligands: Evidence that heptapetide agonists and antagonists bind differently
15. Characterization of non-peptide antagonist and peptide agonist binding sites of the NK-1 receptor with fluorescent ligands
16. Synthesis and characterization of selective fluorescent ligands for the neurokinin NK2 receptor
17. Subcellular compartmentalization of activation and desensitization of responses mediated by NK2 neurokinin receptors
18. Fluorescent pseudo-peptide linear vasopressin antagonists: Design, synthesis and applications
19. Characterization of the RANTES/MIP-1a receptor (CC CKR-1) stably transfected in HEK293 cells and the recombinant ligands
20. Characterisation of macrophage inflammatory protein-5/human CC cytokine-2, a member of the macrophage-inflammatory-protein family of chemokines
21. Synthesis of fluoresceinyl-neurokinin-A, a biologically active probe for NK2 receptors
22. Receptor-mediated endocytosis of CC-chemokines
23. Probing the structure and function of the tachykinin neurokinin-2 receptor through biosynthetic incorporation of fluorescent amino acids at specific sites
24. LD78β, a nonallelic variant of human MIP-1α (LD78α), has enhanced receptor interactions and potent HIV suppressive activity